Managing Partner
CurrentE-merge Capital Partners is a venture capital and growth equity firm dedicated to investing in innovative, early-stage medical device companies and technologies to improve quality of life.
Please complete the CAPTCHA to continue
@acutusmedical.com
✓
4 phones found area 858
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Brad Klos is listed as Managing Partner at E-merge Capital Partners at E-merge Capital Partners, based in Solana Beach, California, United States. AeroLeads shows a work email signal at acutusmedical.com, phone signal with area code 858, and a matched LinkedIn profile for Brad Klos.
Brad Klos previously worked as Managing Partner at E-Merge Capital Partners and Managing Partner at Evolve Medtech Partners. Brad Klos holds Mba, International Business from University Of San Diego.
This section adds company-level context without repeating Brad Klos's masked contact details.
AeroLeads found 1 current-domain work email signal for Brad Klos. Compare company email patterns before reaching out.
Brad currently serves as a Managing Partner of E-merge Capital Partners, a venture capital fund focused on investing in early-stage medical device companies. He is also the Managing Partner at Evolve Medtech, a medical device development company and venture studio and the President and CEO of Cross Vascular, RetractOrtho, Vector Vascular and Boa Medical. He serves as a board advisor to Pathway Medtech, a medical device contract manufacturing company. Previously, he was the President and CEO of Traverse Vascular which was acquired by Teleflex in June 2022. Brad was a co-founder, investor and key advisor of SinglePass Transseptal Inc., which was acquired by Circa Scientific in December 2023. He has held senior management roles at Philips, Acutus Medical, InnerCool Therapies (now Zoll) and MicroTherapeutics (now Medtronic). Brad has experience across multiple medical specialties including all cardiovascular (interventional cardiology, neuro, peripheral and electrophysiology) and key surgical markets (neuro, vascular, orthopedic). He also has worked in the drug delivery and temperature management markets including establishing and managing an international randomized, multi-center clinical trial utilizing catheter-based mild hypothermia for the treatment of acute myocardial infarction (Chill-MI). He currently is an inventor on 12 issued patents with additional patents pending. Brad earned a BA in International Relations and MBA from the University of San Diego.
Listed skills include Medical Devices, Product Launch, Product Marketing, Global Marketing, and 31 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
Solana Beach, California, US
E-merge Capital Partners is a venture capital and growth equity firm dedicated to investing in innovative, early-stage medical device companies and technologies to improve quality of life.
Solana Beach, California, US
Evolve is a medical device technology development company and discovery engine. We partner with inventors, physicians and investors to quickly and efficiently bring ideas from conception to licensing, acquisition or commercialization.
Early-stage medical device company developing products to assist in the treatment of venous disease. E-merge Capital Partners portfolio company co-funded with strategic partner.
Solana Beach, California, US
510k cleared RF transseptal access system that improves upon a widely accepted transseptal approach while maintaining the current physician workflow.
E-merge Capital Partners portfolio company structured as a build-to-buy in the endoscopy space.
RetractOrtho is an E-merge Capital Partners portfolio company that has developed single-use, radiolucent retractor systems for orthopedic surgical procedures. The benefits include faster procedure times, improved reduction and visualization (both direct and fluoroscopic) of the operative field, reduced radiation scatter, and cost savings due to improved.
E-merge Capital Partners portfolio company that developed an over-the-wire RF transseptal access technology used in electrophysiology and structural heart procedures. Acquired by Circa Scientific in December 2023.
Solana Beach, US
Traverse Vascular developed a breakthrough micro-catheter based solution for chronic total occlusions (CTO's). Acquired by Teleflex in June 2022.
CardioPathways developed a technology that uses suction to improve access to the heart via endocardial and epicardial approaches. Initial product development focused on transseptal access. The company was partially funded by a $2m phase II SBIR grant from NIH.
Quick answers generated from the profile data available on this page.
Brad Klos works for E-merge Capital Partners.
Brad Klos is listed as Managing Partner at E-merge Capital Partners at E-merge Capital Partners.
AeroLeads has found 1 work email signal at @acutusmedical.com for Brad Klos at E-merge Capital Partners.
AeroLeads has found 4 phone signal(s) with area code 858 for Brad Klos at E-merge Capital Partners.
Brad Klos is based in Solana Beach, California, United States while working with E-merge Capital Partners.
Brad Klos has worked for E-Merge Capital Partners, Evolve Medtech Partners, Vector Vascular, Pathway Medtech, and Cross Vascular.
You can use AeroLeads to view verified contact signals for Brad Klos at E-merge Capital Partners, including work email, phone, and LinkedIn data when available.
Brad Klos holds Mba, International Business from University Of San Diego.
Brad Klos is listed with skills including Medical Devices, Product Launch, Product Marketing, Global Marketing, Market Development, Business Development, Cross Functional Team Leadership, and Commercialization.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts